Which treatment for early stomach cancer offers the best Long-Term survival?

NCT ID NCT07747688

Recruiting now Knowledge-focused Sponsor: Beijing Friendship Hospital Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study looks back at the medical records of about 5,000 people in China treated for early gastric cancer. It compares different treatment approaches—such as endoscopic removal, laparoscopic surgery, open surgery, or a combination—to see how they affect long-term survival and the chance of the cancer coming back. The goal is to identify which factors most influence outcomes and to provide evidence that helps guide more personalized treatment decisions for early stomach cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: This study could help doctors choose the best treatment for early gastric cancer by comparing long-term outcomes of different surgical and endoscopic approaches.
What could go wrong: Because it is a retrospective observational study, it cannot prove cause and effect. Results may be influenced by patient selection and changes in treatment over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric neoplasm microinvasive gastric cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EARLY GASTRIC CANCER

Contacts and locations

Locations

Beijing Friendship Hospital, Capital Medical University
RECRUITING

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.